Clinical trials review: Idiopathic inflammatory myopathy Chester V. Oddis Clinical Trials Review Pages: 193 - 195
Familial autoimmunity and the idiopathic inflammatory myopathies Ejaz A. ShamimFrederick W. Miller OriginalPaper Pages: 201 - 211
The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies Ingrid E. Lundberg OriginalPaper Pages: 216 - 224
The use of percutaneous needle muscle biopsy in the diagnosis of myopathy David Lacomis OriginalPaper Pages: 225 - 229
Clinical trials for the antiphospholipid syndrome Joan T. Merrill Clinical Trials Review Pages: 233 - 237
Antiphospholipid antibodies and platelets Ann De JongVincent ZibohDick Robbins OriginalPaper Pages: 238 - 245
The pathogenic role of annexin-V in the antiphospholipid syndrome Jacob H. Rand OriginalPaper Pages: 246 - 251
Antiphospholipid antibodies and the endothelium Beverley J. HuntMunther A. Khamashta OriginalPaper Pages: 252 - 255
Treatment of the antiphospholipid antibody syndrome: Progress in the last five years? Michelle Petri OriginalPaper Pages: 256 - 261
Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: Relationship to pathogenesis Mary-Carmen AmigoRomeo GarcĂa-Torres OriginalPaper Pages: 262 - 270